Exchange: NASDAQ·Updated 01:53 PM EDT
NEO logo

NEONeogenomics Inc.

$12.61
$1.14
(9.94%)
Today
EarningsJul 28
Mkt Cap$1.49B
Vol2.39M
News
all
press releases
NeoGenomics (NEO) Soars 7.2%: Is Further Upside Left in the Stock?
NeoGenomics (NEO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
News Placeholder
More News
News Placeholder
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, announced today the pricing of its previously announced private offering of $275 million aggregate principal amount of 0.75% convertible senior notes due 2032 (the notes) to persons...
Business Wire
News Placeholder
NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, announced today that it has commenced a private offering of $275 million aggregate principal amount of convertible senior notes due 2032 (the notes) to persons reasonably believed to...
Business Wire
News Placeholder
NeoGenomics to Present New Research at ASCO Annual Meeting 2026
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, May 29June 2, 2026, in Chicago (booth #32130...
Business Wire
News Placeholder
NeoGenomics to Participate in Upcoming Investor Conferences
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences...
Business Wire
News Placeholder
TD Cowen Issues Positive Forecast for NeoGenomics (NASDAQ:NEO) Stock Price
TD Cowen boosted their target price on shares of NeoGenomics from $13.00 to $14.00 and gave the company a "buy" rating in a research note on Wednesday...
MarketBeat
News Placeholder
NeoGenomics (NASDAQ:NEO) Shares Gap Up Following Analyst Upgrade
NeoGenomics (NASDAQ:NEO) Shares Gap Up on Analyst Upgrade...
MarketBeat
News Placeholder
Wall Street’s Next Biotech Winners Emerge as FDA Acceleration Unleashes New Markets
The biotech and health-tech landscape is entering a new acceleration phase, driven by regulatory momentum, AI integration, and a surge in precision medicine. $NEO, $TGNT, $XTLB, $SAGT, $PRCH, $AKAN
24-7 Market News
News Placeholder
NeoGenomics (NASDAQ:NEO) Upgraded by Leerink Partners to Outperform Rating
Leerink Partners upgraded NeoGenomics from a "market perform" rating to an "outperform" rating and increased their target price for the company from $12.00 to $25.00 in a research report on Wednesday...
MarketBeat
News Placeholder
NeoGenomics (NASDAQ:NEO) Announces Quarterly Earnings Results, Hits Estimates
NeoGenomics (NASDAQ:NEO - Get Free Report) released its earnings results on Tuesday. The medical research company reported $0.01 earnings per share for the quarter, meeting analysts' consensus...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.